• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- Omicron BA.2 tied to more symptoms and, rarely, brain swelling in kids

Lance

MPH, CSP & CIT Retired, CHMM Emeritus
https://www.cidrap.umn.edu/news-per...-more-symptoms-and-rarely-brain-swelling-kids

Omicron BA.2 tied to more symptoms and, rarely, brain swelling in kids


Filed Under:
COVID-19

A UK study suggests that Omicron BA.2 is tied to more symptoms and greater disruption in daily activities than BA.1, and Taiwanese researchers describe fatal cerebral edema in six children hospitalized for BA.2.

Imperial College London researchers tracked SARS-CoV-2 transmission and symptoms among 1,542,510 randomly selected English adults, including 17,448 COVID-19 patients, from May 1, 2020, to Mar 31, 2022.

A greater proportion of BA.2 patients (75.9%) reported at least one of 26 symptoms, compared with 70.0% of those with BA.1, 63.8% with Delta, 54.7% with Alpha, and 45.0% with the wild-type virus.

Patients with wild-type, Alpha, or Delta infections were at highest risk for loss of sense of smell (odds ratios [ORs], 49.7, 37.8, and 73.4, respectively) and taste (ORs, 35.9, 38.9, and 68.1, respectively), while those with BA.1 or BA.2 had higher odds of flu- and cold-like symptoms.

A total of 17.6% of BA.2-infected people said their symptoms had affected their ability to complete daily activities "a lot," compared with 10.7% with BA.1 and 10.5% with Delta infections.

"With restrictions lifted and routine testing limited in many countries, monitoring the changing symptom profiles associated with SARS-CoV-2 infection and effects on daily activities will become increasingly important," the authors wrote.

In Taiwan, researchers examined clinical records from six BA.2-infected children diagnosed as having acute fulminant cerebral edema (usually fatal, rapid-onset brain swelling) from Apr 13 to Jun 30, 2022.

All six initially had shock and significantly elevated inflammatory biomarkers, with five rapidly progressing to multi-organ failure and diffuse blood-vessel clotting and three developing acute respiratory distress.

The researchers said that fever above 41[SUP]o[/SUP]C (105.8[SUP]o[/SUP]F) and atypical complex fever-related seizures are early signs of cerebral edema in pediatric patients. "The rapid and fulminant course highlights a need for close monitoring of cardiopulmonary and hematological functions in such patients, especially during the first day after the onset of neurological signs," they wrote.
 
Back
Top Bottom